Zhang W, Zhao S, Pan C, Zhou Y, Wang C, Rui L
J Virus Erad. 2024; 10(1):100366.
PMID: 38586471
PMC: 10998223.
DOI: 10.1016/j.jve.2024.100366.
Kwak N, Park B, Song Y
Biosensors (Basel). 2023; 13(8).
PMID: 37622855
PMC: 10452572.
DOI: 10.3390/bios13080769.
Tajima S, Maeki T, Nakayama E, Faizah A, Kobayashi D, Isawa H
Viruses. 2023; 15(1).
PMID: 36680278
PMC: 9866982.
DOI: 10.3390/v15010239.
Lim M, Loh Z, Yeo H, Yenamandra S, Kong M, Pang H
Viruses. 2022; 14(12).
PMID: 36560666
PMC: 9786948.
DOI: 10.3390/v14122662.
Lee A, Song J, Seo S
J Microbiol Biotechnol. 2022; 32(8):955-959.
PMID: 35879275
PMC: 9628952.
DOI: 10.4014/jmb.2207.07002.
Epidemiological investigation of swine Japanese encephalitis virus based on RT-RAA detection method.
Nie M, Zhou Y, Li F, Deng H, Zhao M, Huang Y
Sci Rep. 2022; 12(1):9392.
PMID: 35672440
PMC: 9172605.
DOI: 10.1038/s41598-022-13604-4.
National Monitoring of Mosquito Populations and Molecular Analysis of Flavivirus in the Republic of Korea in 2020.
Seo M, Lee H, Yang S, Noh B, Kim T, Lee W
Microorganisms. 2021; 9(10).
PMID: 34683405
PMC: 8538701.
DOI: 10.3390/microorganisms9102085.
Genotype-specific neutralizing antibody titers against Japanese encephalitis virus genotypes 1 and 3 in horses immunized with a genotype 3 vaccine.
Kim H, Yang D, Ji M, Lee S, Hyun B
Clin Exp Vaccine Res. 2020; 9(2):102-107.
PMID: 32864366
PMC: 7445317.
DOI: 10.7774/cevr.2020.9.2.102.
Genetic Characterization of Japanese Encephalitis Virus Genotype 5 Isolated from Patient, South Korea, 2015.
Woo J, Jeong Y, Jo J, Shim S, Ryou J, Kim K
Emerg Infect Dis. 2020; 26(5):1002-1006.
PMID: 32310056
PMC: 7181942.
DOI: 10.3201/eid2605.190977.
Structure analysis and antiviral activity of CW-33 analogues against Japanese encephalitis virus.
Lien J, Wang C, Lai H, Lu C, Lin Y, Gao G
Sci Rep. 2018; 8(1):16595.
PMID: 30413749
PMC: 6226475.
DOI: 10.1038/s41598-018-34932-4.
Changes of Epidemiological Characteristics of Japanese Encephalitis Viral Infection and Birds as a Potential Viral Transmitter in Korea.
Bae W, Kim J, Kim J, Lee J, Hwang E
J Korean Med Sci. 2018; 33(9):e70.
PMID: 29441740
PMC: 5811662.
DOI: 10.3346/jkms.2018.33.e70.
Emerging arboviruses: Why today?.
Gould E, Pettersson J, Higgs S, Charrel R, de Lamballerie X
One Health. 2017; 4:1-13.
PMID: 28785601
PMC: 5501887.
DOI: 10.1016/j.onehlt.2017.06.001.
Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease.
Hegde N, Gore M
Hum Vaccin Immunother. 2017; 13(6):1-18.
PMID: 28301270
PMC: 5529032.
DOI: 10.1080/21645515.2017.1285472.
Antiviral Activity of a Novel Compound CW-33 against Japanese Encephalitis Virus through Inhibiting Intracellular Calcium Overload.
Huang S, Lien J, Chen C, Liu Y, Wang C, Ping C
Int J Mol Sci. 2016; 17(9).
PMID: 27563890
PMC: 5037666.
DOI: 10.3390/ijms17091386.
Comparison of the antigenic relationship between Japanese encephalitis virus genotypes 1 and 3.
Kang B, Hwang J, Moon H, Han S, Kim J, Yang D
Clin Exp Vaccine Res. 2016; 5(1):26-30.
PMID: 26866021
PMC: 4742595.
DOI: 10.7774/cevr.2016.5.1.26.
Construction and immune efficacy of recombinant pseudorabies virus expressing PrM-E proteins of Japanese encephalitis virus genotype І.
Qian P, Zhi X, Wang B, Zhang H, Chen H, Li X
Virol J. 2015; 12:214.
PMID: 26651827
PMC: 4676090.
DOI: 10.1186/s12985-015-0449-3.
Investigation of the genotype III to genotype I shift in Japanese encephalitis virus and the impact on human cases.
Han N, Adams J, Fang W, Liu S, Rayner S
Virol Sin. 2015; 30(4):277-89.
PMID: 26311492
PMC: 8200877.
DOI: 10.1007/s12250-015-3621-4.
The present and future of veterinary vaccines for Japanese encephalitis in Korea.
Nah J, Yang D, Kim H, Song J
Clin Exp Vaccine Res. 2015; 4(2):130-6.
PMID: 26273571
PMC: 4524897.
DOI: 10.7774/cevr.2015.4.2.130.
Molecular epidemiology of Japanese encephalitis in northern Vietnam, 1964-2011: genotype replacement.
Do L, Bui T, Hasebe F, Morita K, Phan N
Virol J. 2015; 12:51.
PMID: 25889499
PMC: 4417254.
DOI: 10.1186/s12985-015-0278-4.
Epidemiology of Japanese encephalitis: past, present, and future prospects.
Wang H, Liang G
Ther Clin Risk Manag. 2015; 11:435-48.
PMID: 25848290
PMC: 4373597.
DOI: 10.2147/TCRM.S51168.